View in EDS

Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.

Saved in:
Bibliographic Details
Title: Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.
Authors: Olszewski AJ; Department of Medicine, Brown University, Providence, RI., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN., Levi I; Soroka University Medical Centre, Be'er-Sheva, Israel., Eradat H; Department of Medicine, University of California, Los Angeles, CA., Abadi U; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Meir Medical Center, Kfar Saba, Israel., Holmes H; Texas Oncology/Baylor-Sammons Cancer Center, Dallas, TX., McKinney MS; Department of Medicine, Duke Cancer Institute, Durham, NC., Woszczyk D; Department of Medicine, Institute of Medical Sciences, University of Opole, Opole, Poland., Giannopoulos K; Department of Medicine, Medical University of Lublin, Lublin, Poland., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland., Jing J; Genentech, Inc, South San Francisco, CA., Li D; Roche (China) Holding Ltd, Shanghai, China., Hamidi H; Genentech, Inc, South San Francisco, CA., Penuel E; Genentech, Inc, South San Francisco, CA., Janousek M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wei MC; Genentech, Inc, South San Francisco, CA., Batlevi C; Genentech, Inc, South San Francisco, CA., Ead W; Genentech, Inc, South San Francisco, CA., Sellam G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Horowitz NA; Rambam Health Care Campus, Technion, Haifa, Israel.
Source: Blood neoplasia [Blood Neoplasia] 2026 May 16; Vol. 3 (3), pp. 100248. Date of Electronic Publication: 2026 May 16 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42327599
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Olszewski+AJ%22">Olszewski AJ</searchLink>; Department of Medicine, Brown University, Providence, RI.<br /><searchLink fieldCode="AU" term="%22Avigdor+A%22">Avigdor A</searchLink>; Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Babu+S%22">Babu S</searchLink>; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN.<br /><searchLink fieldCode="AU" term="%22Levi+I%22">Levi I</searchLink>; Soroka University Medical Centre, Be'er-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Eradat+H%22">Eradat H</searchLink>; Department of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Abadi+U%22">Abadi U</searchLink>; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Meir Medical Center, Kfar Saba, Israel.<br /><searchLink fieldCode="AU" term="%22Holmes+H%22">Holmes H</searchLink>; Texas Oncology/Baylor-Sammons Cancer Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22McKinney+MS%22">McKinney MS</searchLink>; Department of Medicine, Duke Cancer Institute, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Woszczyk+D%22">Woszczyk D</searchLink>; Department of Medicine, Institute of Medical Sciences, University of Opole, Opole, Poland.<br /><searchLink fieldCode="AU" term="%22Giannopoulos+K%22">Giannopoulos K</searchLink>; Department of Medicine, Medical University of Lublin, Lublin, Poland.<br /><searchLink fieldCode="AU" term="%22Jurczak+W%22">Jurczak W</searchLink>; Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland.<br /><searchLink fieldCode="AU" term="%22Jing+J%22">Jing J</searchLink>; Genentech, Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Li+D%22">Li D</searchLink>; Roche (China) Holding Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Hamidi+H%22">Hamidi H</searchLink>; Genentech, Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Penuel+E%22">Penuel E</searchLink>; Genentech, Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Janousek+M%22">Janousek M</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wei+MC%22">Wei MC</searchLink>; Genentech, Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Batlevi+C%22">Batlevi C</searchLink>; Genentech, Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Ead+W%22">Ead W</searchLink>; Genentech, Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Sellam+G%22">Sellam G</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Horowitz+NA%22">Horowitz NA</searchLink>; Rambam Health Care Campus, Technion, Haifa, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918841988906676%22">Blood neoplasia</searchLink> [Blood Neoplasia] 2026 May 16; Vol. 3 (3), pp. 100248. <i>Date of Electronic Publication: </i>2026 May 16 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918841988906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2950-3280 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503280%22">29503280 </searchLink><i>NLM ISO Abbreviation: </i>Blood Neoplasia <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42327599
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bneo.2026.100248
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100248
    Titles:
      – TitleFull: Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Olszewski AJ
      – PersonEntity:
          Name:
            NameFull: Avigdor A
      – PersonEntity:
          Name:
            NameFull: Babu S
      – PersonEntity:
          Name:
            NameFull: Levi I
      – PersonEntity:
          Name:
            NameFull: Eradat H
      – PersonEntity:
          Name:
            NameFull: Abadi U
      – PersonEntity:
          Name:
            NameFull: Holmes H
      – PersonEntity:
          Name:
            NameFull: McKinney MS
      – PersonEntity:
          Name:
            NameFull: Woszczyk D
      – PersonEntity:
          Name:
            NameFull: Giannopoulos K
      – PersonEntity:
          Name:
            NameFull: Jurczak W
      – PersonEntity:
          Name:
            NameFull: Jing J
      – PersonEntity:
          Name:
            NameFull: Li D
      – PersonEntity:
          Name:
            NameFull: Hamidi H
      – PersonEntity:
          Name:
            NameFull: Penuel E
      – PersonEntity:
          Name:
            NameFull: Janousek M
      – PersonEntity:
          Name:
            NameFull: Wei MC
      – PersonEntity:
          Name:
            NameFull: Batlevi C
      – PersonEntity:
          Name:
            NameFull: Ead W
      – PersonEntity:
          Name:
            NameFull: Sellam G
      – PersonEntity:
          Name:
            NameFull: Horowitz NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 05
              Text: 2026 May 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2950-3280
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Blood neoplasia
              Type: main
ResultId 1